Arm Holdings (ARM) fell about 10% to $205.68 in early trading on October 30, 2026, extending a slide of roughly 33% from its October 2 closing peak of $307.49. Nothing in the news record explains the drop. The balance of evidence leans negative with high conviction (3 of 4 points): the daily and weekly trends point down, and the stock is lagging both the market and its chip peers.
Why it matters
The most recent company-relevant headlines are three weeks old, and none of them accounts for today's move. On September 30, Synopsys announced a Reuters-reported licensing deal with Amazon Web Services worth more than $1 billion, plus an AI chip-design partnership with OpenAI. On October 1, Huawei unveiled phones built around homegrown chip design to offset US curbs. These are sector stories, and ARM peaked the next day. Whatever is driving the stock this morning is not in the record, and a 10% single-day drop with no headline usually means positioning is unwinding rather than the business changing.
The market is not the cause. Over five days ARM is down 2.2% while SPY is up 0.7% and the semiconductor ETF SOXX is up 8.0%. That puts the stock about 10 points behind its sector over the week. The gap is wider over a month: ARM is down 29.0%, SOXX down 9.4%. Over 50 days ARM trails the S&P 500 by 12.1 points and SOXX by 8.8. Most of the damage is specific to the stock. The year-to-date gain of 88.2% (SOXX: 70.6%) shows how much was priced in before the October peak.
The argument about ARM is mostly about how much to pay for a royalty model. Morningstar's analysis describes a business that licenses CPU architecture and earns royalties on every chip shipped, and stays neutral. The constructive case came when CNBC reported technician Katie Stockton's view that ARM had broken above its 50-day average and daily cloud near $275, with positive momentum signals. That level is now far above the price, so the technical case behind that article has failed. The market's own verdict is the downtrend.
Analysts remain far more optimistic than the tape. Forty cover the stock, with a mean price target of $290.71, a low of $125 and a high of $500. The shares trade 29.2% below that mean. The spread, from below the 52-week low's neighborhood to more than double the price, says the analysts do not agree on what the stock is worth, and a 40-name average is a poor anchor when the price is breaking down.
What the evidence says
The long-term trend is down. The price is below its 40-week average and below its 10-week average, and it sits 53.2% under the 52-week high of $439.46 while still 96.7% above the 52-week low of $104.55. The thesis is weakened rather than broken: a stock that has roughly doubled from its low and is up 88% this year has not lost its longer-term gains. But the phase is a markdown after a blow-off peak, with the 50-day average at $258.72 well above the price and the 200-day average at $228.92 now overhead as resistance.
For the next 2 to 6 weeks the balance of evidence leans negative, and conviction is high at 3 of 4 points. The daily trend runs with the weekly downtrend, ARM lags the S&P 500 over 50 days, and it lags SOXX over the same period. That alignment matters because pullbacks inside a downtrend tend to be sold; each of the three is a separate piece of evidence pointing the same way.
The strongest case against this reading is the bounce history. After one-day drops of more than 5%, the stock was higher a month later in 70.9% of 151 cases, against 61.8% for a typical month, with a median one-month move of 5.38%. The RSI of 30.42 also shows the stock is oversold, and volume so far today is 80.4% below its 20-day average, so the session is young and the move is not yet confirmed by heavy trading. These facts explain why conviction is not a perfect 4 of 4, but they describe a likely bounce, not a change of trend. A bounce into $225 to $229 would meet resistance from the round number and the 200-day average.
Levels that matter
The structure sits below $225, a round number where sellers have shown up on rallies. Just above it is the 200-day average at $228.92. The weekly downtrend would end only on a weekly close above $238.4, a former swing zone that is the next overhead barrier. Above that sit $250 and the 50-day average at $258.72.
The breakout level is a daily close below $200, a round number just under the current price. From there the math points to the 52-week low of $104.55, with $175 as an intermediate support. The level that would make a downside break wrong is $228.46, which is $225 plus a quarter of the 14-day average true range. Against that stop, a move to $104.55 gives 3.4 to 1, which clears the 3 to 1 mark that makes a breakout worth its risk. That figure assumes the $200 close happens first; at today's price the trade has not triggered.
What would change the picture
The picture changes on a weekly close above $238.4. That would put the price above the 200-day average and the swing zone together, and it would be the first sign that buyers are back. The one non-price fact that could do it is an earnings report on November 4 whose guidance lifts the revenue outlook, because that would answer the question of why the stock fell before the market has an explanation.
What to watch
- Earnings, November 4, 2026: the one number that matters is forward revenue guidance, which shows whether royalty growth supports the valuation the shares carried at the October peak.
- Sector events: SOXX rose 8.0% over five days while ARM fell, so watch whether chip stocks keep rising without it. Swings in AI sentiment, described by Bloomberg as a lurch from fear to greed, move the stock before any company news, as do US curbs on China chips.
- Valuation vs consensus: at $205.68 the stock is 29.2% below the $290.71 mean target, but the target range of $125 to $500 shows how little the analysts agree on.